| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.087 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |